Government data show prescription drug prices declined 3.1 percent over the past year, the steepest annual drop since 1963, with seven consecutive months of decreases. Supported claims include the creation of the TrumpRx discount platform, while attributions of the decline to specific administration policies remain unverified. Analyses differ on whether the trend reflects effective executive pressure, limited market relief, or risks of coercive intervention.